OHI on NYSE

OMEGA HEALTHCARE INVESTORS INC

OMEGA HEALTHCARE INVESTORS INC is an American real estate investment trust, incorporated in Maryland.¹ It is headquartered in Hunt Valley, Maryland.¹ Its shares trade on NYSE under the symbol OHI.¹

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with American Homes 4 Rent, CubeSmart or DiamondRock Hospitality Co, or pick any stock.

TickerOHI on NYSE¹
IndustryReal Estate Investment Trusts¹
HeadquartersHunt Valley, Maryland¹
Incorporated inMD²
Business address303 International Circle,, Suite 200, Hunt Valley, Md 21030²
Filer categoryLarge accelerated filer²

See how the biggest companies compare on our leaderboards

Omega Healthcare Investors, Inc. (“Parent”) is a Maryland corporation that invests in healthcare-related real estate properties located in the United States (“U.S.”), the United Kingdom (“U.K.”) and Canada, which investments comprise our one reportable segment. Omega became a publicly traded company listed on the New York Stock Exchange in 1992. Our primary objective is to provide strong returns to our investors, while serving as the preferred capital partner to our third-party healthcare operating companies and affiliates (collectively, our “operators”) and other third-party high quality healthcare operators so they can concentrate on providing a high level of care for their resident-patients.⁴ From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

49.6%Net margin⁵

13.2%Revenue growth, 2025⁵

11.4%Return on equity⁵

0.82×Debt to equity⁵

Where the money goes

Where each dollar of revenue went, fiscal 2025

Other costsProfit

Other costs49¢$585.2M
Income tax1¢$14.7M
Profit50¢$590.2M

Out of $1.2B in revenue.⁵

Where each dollar of operating cash went, fiscal 2025

Dividends paidKept or used elsewhere

Dividends paid89¢$780.4M
Kept or used elsewhere11¢$98.2M

Out of $878.6M of cash from operations.⁵

Financial statements

Revenue⁶⁷⁸⁹⁵$1.2B in 2025+28% since 2019

Net income⁶⁷⁸⁹⁵$590.2M in 2025+68% since 2019

Every line of the income statement as filed: the last 3 fiscal years, latest first.⁵

Period ending	2025-12-31	2024-12-31	2023-12-31
Rental income	$1.0B	$887.9M	$826.4M
Interest income	$175.1M	$157.2M	$119.9M
Miscellaneous income	$13.0M	$6.3M	$3.5M
Total revenues	$1.2B	$1.1B	$949.7M
Depreciation and amortization	$325.2M	$304.6M	$319.7M
General and administrative	$104.1M	$88.0M	$81.5M
Real estate taxes	$14.4M	$14.6M	$15.0M
Acquisition, merger and transition related costs	$4.2M	$11.6M	$5.3M
Impairment on real estate properties	$22.6M	$23.8M	$91.9M
Provision (recovery) for credit losses	$2.3M	-$15.5M	$44.6M
Interest expense	$215.0M	$221.7M	$235.5M
Total expenses	$688.0M	$648.9M	$793.6M
Other income - net	$50.1M	$6.8M	$20.3M
Gain (loss) on debt extinguishment	$5.0M	-$1.7M	-$492.0K
Gain on assets sold - net	$67.3M	$13.2M	$79.7M
Total other income	$122.4M	$18.2M	$99.5M
Income before income tax expense and income from unconsolidated entities	$624.4M	$420.7M	$255.6M
Income tax expense	-$14.7M	-$10.9M	-$6.3M
(Loss) income from unconsolidated entities	-$218.0K	$7.9M	-$582.0K
Net income	$609.5M	$417.8M	$248.8M
Net income attributable to noncontrolling interest	-$19.3M	-$11.5M	-$6.6M
Net income available to common stockholders	$590.2M	$406.3M	$242.2M
Net income available to common stockholders	$1.96	$1.57	$1.01
Net income available to common stockholders	$1.94	$1.55	$1.00

Total assets¹³⁶⁷⁸⁹⁵$10.0B in 2025+3% since 2019

Total liabilities¹³⁶⁷⁸⁹⁵$4.6B in 2025−16% since 2019

Shareholders’ equity¹³⁶⁷⁸⁹⁵$5.2B in 2025+25% since 2019

Cash⁶⁷⁸⁹⁵$27.0M in 2025+12% since 2019

Long-term debt¹³⁶⁷⁸⁹⁵$4.3B in 2025−17% since 2019

Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.⁵

Period ending	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Buildings and improvements	$7.9B	$7.3B
Land	$1.2B	$996.7M
Furniture and equipment	$539.8M	$510.1M
Construction in progress	$12.5M	$210.9M
Total real estate assets	$9.6B	$9.1B
Less accumulated depreciation	-$2.9B	-$2.7B
Real estate assets - net	$6.7B	$6.3B
Investments in direct financing leases - net		$9.5M
Real estate loans receivable - net	$1.4B	$1.4B
Investments in unconsolidated entities	$414.1M	$88.7M
Assets held for sale	$4.0M	$56.2M
Total real estate investments	$8.5B	$7.9B
Non-real estate loans receivable - net	$330.3M	$332.3M
Total investments	$8.8B	$8.3B
Cash and cash equivalents	$27.0M	$518.3M	$442.8M
Restricted cash	$27.5M	$30.4M	$1.9M
Contractual receivables - net	$9.7M	$12.6M
Other receivables and lease inducements	$278.6M	$249.3M
Goodwill	$644.6M	$643.7M
Other assets	$229.4M	$189.5M
Total assets	$10.0B	$9.9B
Revolving credit facility	$242.0M
Secured borrowings		$243.3M
Senior notes and other unsecured borrowings - net	$4.0B	$4.6B
Accrued expenses and other liabilities	$352.5M	$328.2M
Total liabilities	$4.6B	$5.2B
Common stock $0.10 par value authorized - 700,000 shares, issued and outstanding - 295,539 shares as of December 31, 2025 and 279,129 shares as of December 31, 2024	$29.6M	$27.9M
Additional paid-in capital	$8.7B	$7.9B
Cumulative net earnings	$4.7B	$4.1B
Cumulative dividends paid	-$8.3B	-$7.5B
Accumulated other comprehensive income	$79.0M	$22.7M
Total stockholders' equity	$5.2B	$4.5B
Noncontrolling interest	$259.2M	$194.2M
Total equity	$5.4B	$4.7B	$3.8B	$3.8B
Total liabilities and equity	$10.0B	$9.9B
Preferred stock, par value (in dollars per share)	$1.00	$1.00
Preferred stock, shares authorized	20.0M shares	20.0M shares
Preferred stock, shares issued	0 shares	0 shares
Preferred stock, shares outstanding	0 shares	0 shares
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, shares authorized	700.0M shares	350.0M shares
Common stock, shares issued	295.5M shares	279.1M shares
Common stock, shares outstanding	295.5M shares	279.1M shares

Period ending	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Buildings and improvements	$7.9B	$7.3B
Land	$1.2B	$996.7M
Furniture and equipment	$539.8M	$510.1M
Construction in progress	$12.5M	$210.9M
Total real estate assets	$9.6B	$9.1B
Less accumulated depreciation	-$2.9B	-$2.7B
Real estate assets - net	$6.7B	$6.3B
Investments in direct financing leases - net		$9.5M
Real estate loans receivable - net	$1.4B	$1.4B
Investments in unconsolidated entities	$414.1M	$88.7M
Assets held for sale	$4.0M	$56.2M
Total real estate investments	$8.5B	$7.9B
Non-real estate loans receivable - net	$330.3M	$332.3M
Total investments	$8.8B	$8.3B
Cash and cash equivalents	$27.0M	$518.3M	$442.8M
Restricted cash	$27.5M	$30.4M	$1.9M
Contractual receivables - net	$9.7M	$12.6M
Other receivables and lease inducements	$278.6M	$249.3M
Goodwill	$644.6M	$643.7M
Other assets	$229.4M	$189.5M
Total assets	$10.0B	$9.9B
Revolving credit facility	$242.0M
Secured borrowings		$243.3M
Senior notes and other unsecured borrowings - net	$4.0B	$4.6B
Accrued expenses and other liabilities	$352.5M	$328.2M
Total liabilities	$4.6B	$5.2B
Common stock $0.10 par value authorized - 700,000 shares, issued and outstanding - 295,539 shares as of December 31, 2025 and 279,129 shares as of December 31, 2024	$29.6M	$27.9M
Additional paid-in capital	$8.7B	$7.9B
Cumulative net earnings	$4.7B	$4.1B
Cumulative dividends paid	-$8.3B	-$7.5B
Accumulated other comprehensive income	$79.0M	$22.7M
Total stockholders' equity	$5.2B	$4.5B
Noncontrolling interest	$259.2M	$194.2M
Total equity	$5.4B	$4.7B	$3.8B	$3.8B
Total liabilities and equity	$10.0B	$9.9B
Preferred stock, par value (in dollars per share)	$1.00	$1.00
Preferred stock, shares authorized	20.0M shares	20.0M shares
Preferred stock, shares issued	0 shares	0 shares
Preferred stock, shares outstanding	0 shares	0 shares
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, shares authorized	700.0M shares	350.0M shares
Common stock, shares issued	295.5M shares	279.1M shares
Common stock, shares outstanding	295.5M shares	279.1M shares

Cash from operations⁶⁷⁸⁹⁵$878.6M in 2025+59% since 2019

Dividends paid⁶⁷⁸⁹⁵$780.4M in 2025+38% since 2019

Every line of the cash flow as filed: the last 3 fiscal years, latest first.⁵

Period ending	2025-12-31	2024-12-31	2023-12-31
Net income	$609.5M	$417.8M	$248.8M
Depreciation and amortization	$325.2M	$304.6M	$319.7M
Impairment on real estate properties	$22.6M	$23.8M	$91.9M
Straight-line rent and other write-offs	$28.0M	$4.2M	$20.6M
Provision (recovery) for credit losses	$2.3M	-$15.5M	$44.6M
Amortization of deferred financing costs and loss on debt extinguishment	$968.0K	$12.1M	$14.2M
Stock-based compensation expense	$44.2M	$36.7M	$35.1M
Gain on assets sold - net	-$67.3M	-$13.2M	-$79.7M
Straight-line rent and effective interest receivables	-$50.3M	-$43.0M	-$41.8M
Interest paid-in-kind	-$13.6M	-$11.5M	-$11.4M
Loss from unconsolidated entities	$6.1M	$1.9M	$182.0K
Other non-cash items	-$26.3M	-$1.5M	-$9.3M
Contractual receivables	$2.9M	-$845.0K	-$3.7M
Lease inducements	-$9.0M	-$61.0K	-$15.2M
Other operating assets and liabilities	$3.2M	$33.8M	$3.8M
Net cash provided by operating activities	$878.6M	$749.4M	$617.7M
Acquisition of real estate	-$683.0M	-$408.6M	-$262.5M
Net proceeds from sale of real estate investments	$282.8M	$95.0M	$585.0M
Investments in construction in progress	-$33.6M	-$69.0M	-$44.5M
Investment in loan receivables and other	-$173.6M	-$470.0M	-$420.6M
Collection of loan principal	$246.6M	$207.6M	$165.2M
Investments in unconsolidated entities	-$122.1M	-$971.0K	-$12.3M
Distributions from unconsolidated entities in excess of earnings	$12.9M	$1.0M	$8.8M
Capital improvements to real estate investments	-$80.9M	-$37.8M	-$38.0M
Proceeds from foreign currency forward contracts	$4.2M	$8.4M	$11.4M
Receipts from insurance proceeds	$6.8M	$3.1M	$6.8M
Net cash used in investing activities	-$539.8M	-$671.2M	-$770.0K
Proceeds from long-term borrowings	$1.3B	$657.8M	$507.1M
Payments of long-term borrowings	-$1.9B	-$1.1B	-$735.0M
Payments of financing related costs	-$27.3M	-$7.0M	-$3.8M
Net proceeds from issuance of common stock	$606.8M	$1.2B	$336.4M
Dividends paid	-$780.4M	-$685.4M	-$643.9M
Net payments to noncontrolling members of consolidated joint venture		$545.0K	-$202.0K
(Payments for) proceeds from derivative instruments	-$2.2M		$92.6M
Redemption of Omega OP Units	-$6.2M	-$684.0K	-$77.0K
Distributions to Omega OP Unit Holders	-$43.9M	-$29.3M	-$26.4M
Net cash (used in) provided by financing activities	-$838.3M	$26.3M	-$473.3M
Effect of foreign currency translation on cash, cash equivalents and restricted cash	$5.3M	-$580.0K	$430.0K
(Decrease) increase in cash, cash equivalents and restricted cash	-$494.2M	$104.0M	$144.1M

Compare OMEGA HEALTHCARE INVESTORS INC with another company

Corporate structure

OMEGA HEALTHCARE INVESTORS INC sits at the top of its group. 916 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of OMEGA HEALTHCARE INVESTORS INC

Cohen & Steers Filed SCHEDULE 13G on OMEGA HEALTHCARE INVESTORS INC, latest Aug 14, 2026 (8 filings since Nov 14, 2024)
VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on OMEGA HEALTHCARE INVESTORS INC, latest Apr 30, 2026
VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on OMEGA HEALTHCARE INVESTORS INC, latest Apr 29, 2026
VANGUARD GROUP INC Filed SCHEDULE 13G/A on OMEGA HEALTHCARE INVESTORS INC, latest Mar 27, 2026 (4 filings since Feb 10, 2022)
State Street Corporation Filed SCHEDULE 13G on OMEGA HEALTHCARE INVESTORS INC, latest Nov 10, 2025 (6 filings since Feb 10, 2022)
BlackRock Filed SCHEDULE 13G/A on OMEGA HEALTHCARE INVESTORS INC, latest Apr 30, 2025 (6 filings since Jan 25, 2022)

OMEGA HEALTHCARE INVESTORS INC Hunt Valley, Maryland
- 10. Subsidiary · California, United States
- 100. Subsidiary · Delaware, United States
- 101. Subsidiary · Delaware, United States
- 102. Subsidiary · Delaware, United States
- 103. Subsidiary · Delaware, United States
- 104. Subsidiary · Delaware, United States
- 105. Subsidiary · Delaware, United States
- 106. Subsidiary · Delaware, United States
- 107. Subsidiary · Delaware, United States
- 108. Subsidiary · Delaware, United States
- 109. Subsidiary · Delaware, United States
- 11. Subsidiary · Michigan, United States
- 110. Subsidiary · Delaware, United States
- 111. Subsidiary · Delaware, United States
- 112. Subsidiary · Delaware, United States
- 113. Subsidiary · Delaware, United States
- 114. Subsidiary · Delaware, United States
- 115. Subsidiary · Delaware, United States
- 116. Subsidiary · Delaware, United States
- 117. Subsidiary · Delaware, United States
- 118. Subsidiary · Delaware, United States
- 119. Subsidiary · Delaware, United States
- 12. Subsidiary · Delaware, United States
- 120. Subsidiary · Delaware, United States
- 121. Subsidiary · Delaware, United States
- and 890 more

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What OMEGA HEALTHCARE INVESTORS INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Land	$1.2B⁵ Dec 31, 2025	$996.7M⁵ Dec 31, 2024	+18.3%
Operating-lease assets (leased space)	$27.3M⁵ Dec 31, 2025	$28.3M⁵ Dec 31, 2024	−3.6%

Real estate and locations

Item	Latest	A year before	Change
Real estate investments, net	$6.7B⁵ Dec 31, 2025	$6.3B⁵ Dec 31, 2024	+5.7%
Real estate investments, at cost	$9.6B⁵ Dec 31, 2025	$9.1B⁵ Dec 31, 2024	+6.3%
Real estate accumulated depreciation	$2.9B⁵ Dec 31, 2025	$2.7B⁵ Dec 31, 2024	+7.7%
Real estate properties	1,027⁵ Dec 31, 2025	1,026⁹ Dec 31, 2024	+0.1%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$27.0M⁵ Dec 31, 2025	$518.3M⁵ Dec 31, 2024	−94.8%
Stakes in other companies (equity method)	$414.1M⁵ Dec 31, 2025	$88.7M⁵ Dec 31, 2024	+366.8%
Loans, net of allowance	$1.4B⁵ Dec 31, 2025	$1.4B⁵ Dec 31, 2024	−3.3%

Intangibles and goodwill

Item	Latest	A year before	Change
Goodwill	$644.6M⁵ Dec 31, 2025	$643.7M⁵ Dec 31, 2024	+0.1%
Finite-lived intangibles, gross	$34.0M⁵ Dec 31, 2025	$31.9M⁵ Dec 31, 2024	+6.6%
Accumulated amortization	$6.8M⁵ Dec 31, 2025	$3.8M⁵ Dec 31, 2024	+79.4%
Finite-lived intangibles, net	$27.2M⁵ Dec 31, 2025	$28.1M⁵ Dec 31, 2024	−3.2%

Properties, in its own words

At December 31, 2025, our consolidated owned real estate assets include SNFs and ALFs and to a lesser extent ILFs, specialty facilities and CCRCs. Our facilities are located in 42 states, Washington, D.C., the U.K. and Jersey.

The following tables present the geographic concentration by property type and by investment for our consolidated real estate assets held for investment as of December 31, 2025 (dollars in thousands):

The rest of Item 2

Number of Facilities

Specialty Facilities

Location · SNFs · ALFs · ILFs · and Other · Total Facilities · % of Total

United Kingdom · — · 263 · — · — · 263 · 28.1%

Texas · 80 · 4 · 4 · 4 · 92 · 9.8%

Indiana · 55 · 5 · 6 · 3 · 69 · 7.4%

California · 48 · 3 · — · 1 · 52 · 5.6%

Florida · 42 · 2 · 1 · — · 45 · 4.8%

North Carolina · 44 · 1 · — · — · 45 · 4.8%

Virginia · 22 · 2 · — · — · 24 · 2.6%

Pennsylvania · 24 · 4 · 4 · — · 32 · 3.4%

Ohio · 23 · 3 · — · 3 · 29 · 3.1%

New York · — · 1 · — · — · 1 · 0.1%

Remaining Locations (33 States) · 223 · 51 · 4 · 6 · 284 · 30.3%

Total · 561 · 339 · 19 · 17 · 936 · 100.0%

% of Total · 59.9% · 36.3% · 2.0% · 1.8% · 100.0%

Gross Investment

Specialty Facilities

Location · SNFs · ALFs · ILFs · and Other · Total · % of Total

United Kingdom · — · 1,719,740 · — · — · 1,719,740 · 17.9%

Texas · 667,969 · 32,349 · 142,792 · 60,500 · 903,610 · 9.4%

Indiana · 519,155 · 32,211 · 29,472 · 48,989 · 629,827 · 6.5%

California · 507,462 · 33,806 · — · 42,146 · 583,414 · 6.1%

Florida · 360,079 · 31,735 · 81,606 · — · 473,420 · 4.9%

North Carolina · 396,776 · 12,692 · — · 1,024 · 410,492 · 4.3%

Virginia · 355,400 · 34,053 · — · — · 389,453 · 4.0%

Pennsylvania · 279,046 · 69,776 · 15,444 · — · 364,266 · 3.8%

Ohio · 270,866 · 37,359 · — · 49,430 · 357,655 · 3.7%

New York · — · 329,586 · — · — · 329,586 · 3.4%

Remaining Locations (33 States) · 2,106,609 · 1,169,493 · 63,112 · 132,705 · 3,471,919 · 36.0%

Total · 5,463,362 · 3,502,800 · 332,426 · 334,794 · 9,633,382 · 100.0%

% of Total · 56.6% · 36.4% · 3.5% · 3.5% · 100.0%

Item 2 of the 10-K filed Feb 9, 2026.⁴

Leadership

Who has led OMEGA HEALTHCARE INVESTORS INC, and when. Pick a name to see everywhere that person has worked.

2010201520202025

Chief executive officerC. Taylor Pickett Jan 4, 2006 to now¹⁴
PresidentMatthew Paul Gourmand Jan 10, 2025 to now¹⁵
Chief financial officerNeal Ballew Sep 30, 2026 to now¹⁶
Chief operating officerDaniel J. Booth Jan 4, 2006 to Jan 3, 2025¹⁷

Board members and other officers (21)

CHIEF ACCOUNTING OFFICERLucas M. Golem Aug 7, 2026 to now¹⁸
Chief Accounting OfficerNeal Ballew Oct 26, 2020 to now¹⁹
Chief Corp Development OfficerSteven J. Insoft Apr 3, 2015 to Feb 11, 2022²⁰
Senior Vice PresidentR. Lee Crabill Jan 4, 2007 to Apr 2, 2015²¹
Chief Accounting OfficerMichael Ritz Apr 16, 2007 to Jul 2, 2020²²
Board memberLisa Egbuonu-Davis Aug 2, 2021 to now²³
Board memberKevin J. Jacobs Oct 26, 2020 to now²⁴
Board memberKapila K. Anand Jun 11, 2018 to now²⁵
Board memberBurke W. Whitman Nov 5, 2018 to now²⁶
Board memberBen W. Perks Apr 3, 2015 to Mar 26, 2019²⁷
Board memberCraig M. Bernfield Apr 3, 2015 to Jun 11, 2018²⁸
Board memberNorman Bobins Apr 3, 2015 to Jun 11, 2019²⁹
Board memberBarbara B. Hill Apr 5, 2013 to now³⁰
Board memberCraig R. Callen Apr 5, 2013 to now³¹
Board memberBernard J. Korman Jan 4, 2006 to Dec 26, 2017³²
Board memberC. Taylor Pickett Jan 4, 2006 to now¹⁴
Board memberEdward Lowenthal Jan 4, 2006 to Jun 9, 2021³³
Board memberHarold J. Kloosterman Jan 4, 2006 to May 18, 2017³⁴
Board memberStephen D. Plavin Jan 4, 2006 to now³⁵
Board memberThomas F. Franke Jan 4, 2006 to May 25, 2016³⁶
General counselGail D. Makode Nov 8, 2019 to now³⁷

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

10. California³
100. Delaware³
101. Delaware³
102. Delaware³
103. Delaware³
104. Delaware³
105. Delaware³
106. Delaware³
107. Delaware³
108. Delaware³
109. Delaware³
11. Michigan³
110. Delaware³
111. Delaware³
112. Delaware³
113. Delaware³
114. Delaware³
115. Delaware³
116. Delaware³
117. Delaware³
118. Delaware³
119. Delaware³
12. Delaware³
120. Delaware³

All 915 listed subsidiaries

121. Delaware³
122. Delaware³
123. Delaware³
124. Delaware³
125. Delaware³
126. Delaware³
127. Delaware³
128. Delaware³
129. Delaware³
13. California³
130. Delaware³
131. Delaware³
132. Delaware³
133. Delaware³
134. Delaware³
135. Delaware³
136. Delaware³
137. Delaware³
138. Delaware³
139. Delaware³
14. California³
140. Delaware³
141. Delaware³
142. Delaware³
143. Delaware³
144. Delaware³
145. Delaware³
146. Delaware³
147. Delaware³
148. Delaware³
149. Delaware³
15. United Kingdom³
150. Delaware³
151. Delaware³
152. Delaware³
153. Delaware³
154. Delaware³
155. Delaware³
156. Delaware³
157. Delaware³
158. Delaware³
159. Delaware³
16. New Mexico³
160. Delaware³
161. Delaware³
162. Delaware³
163. Delaware³
164. Delaware³
165. Delaware³
166. United Kingdom³
167. Maryland³
168. Maryland³
169. Delaware³
17. Delaware³
170. Delaware³
171. Mississippi³
172. Ohio³
173. Delaware³
174. Delaware³
175. Arizona³
176. Delaware³
177. Delaware³
178. Delaware³
179. Delaware³
18. United Kingdom³
180. Delaware³
181. Delaware³
182. North Carolina³
183. North Carolina³
184. North Carolina³
185. Louisiana³
186. Louisiana³
187. Florida³
188. Florida³
189. Florida³
19. Delaware³
190. Florida³
191. Florida³
192. Florida³
193. North Carolina³
194. North Carolina³
195. Delaware³
196. Florida³
197. Florida³
198. Florida³
199. Florida³
20. Delaware³
200. Florida³
201. Louisiana³
202. Florida³
203. Louisiana³
204. Florida³
205. Delaware³
206. Delaware³
207. Florida³
208. North Carolina³
209. Florida³
21. Delaware³
210. Florida³
211. Florida³
212. Delaware³
213. Mississippi³
214. Mississippi³
215. Florida³
216. Florida³
217. Mississippi³
218. Florida³
219. Florida³
22. Delaware³
220. Florida³
221. Florida³
222. Florida³
223. Florida³
224. Delaware³
225. Delaware³
226. Delaware³
227. Delaware³
228. Delaware³
229. North Carolina³
23. Delaware³
230. Florida³
231. Florida³
232. Mississippi³
233. Florida³
234. Florida³
235. Florida³
236. Mississippi³
237. Florida³
238. Florida³
239. Mississippi³
24. Delaware³
240. Florida³
241. North Carolina³
242. Delaware³
243. Maryland³
244. Florida³
245. Delaware³
246. Delaware³
247. Delaware³
248. Delaware³
249. Arizona³
25. Delaware³
250. Delaware³
251. Maryland³
252. Delaware³
253. California³
254. Delaware³
255. Delaware³
256. Delaware³
257. Delaware³
258. Delaware³
259. Delaware³
26. Delaware³
260. Delaware³
261. Delaware³
262. United Kingdom³
263. Delaware³
264. Delaware³
265. Delaware³
266. Delaware³
267. Delaware³
268. Ohio³
269. Ohio³
27. Delaware³
270. Ohio³
271. United Kingdom³
272. United Kingdom³
273. Jersey³
274. United Kingdom³
275. United Kingdom³
276. United Kingdom³
277. Illinois³
278. Maryland³
279. Delaware³
28. Delaware³
280. Delaware³
281. Delaware³
282. Delaware³
283. Delaware³
284. Delaware³
285. United Kingdom³
286. Delaware³
287. Delaware³
288. Delaware³
289. Delaware³
29. Delaware³
290. Ohio³
291. Ohio³
292. Ohio³
293. Delaware³
294. Delaware³
295. Delaware³
296. Delaware³
297. Delaware³
298. Delaware³
299. Delaware³
30. Delaware³
300. Texas³
301. Ohio³
302. Delaware³
303. Delaware³
304. Delaware³
305. Delaware³
306. Delaware³
307. Delaware³
308. Illinois³
309. Delaware³
31. Pennsylvania³
310. Delaware³
311. Delaware³
312. Delaware³
313. Delaware³
314. Delaware³
315. Delaware³
316. Delaware³
317. Delaware³
318. Delaware³
319. Delaware³
32. Delaware³
320. Delaware³
321. Delaware³
322. Delaware³
323. Delaware³
324. Delaware³
325. Delaware³
326. Delaware³
327. Delaware³
328. Delaware³
329. Delaware³
33. Maryland³
330. Delaware³
331. Delaware³
332. Delaware³
333. Delaware³
334. Delaware³
335. Delaware³
336. Delaware³
337. Delaware³
338. Delaware³
339. Delaware³
34. Delaware³
340. Delaware³
341. Delaware³
342. Delaware³
343. Delaware³
344. Delaware³
345. Delaware³
346. New Mexico³
347. New Mexico³
348. New Mexico³
349. Ohio³
35. Delaware³
350. Delaware³
351. Delaware³
352. Delaware³
353. Delaware³
354. Delaware³
355. Delaware³
356. Delaware³
357. Mississippi³
358. Delaware³
359. Delaware³
36. Delaware³
360. Connecticut³
361. Delaware³
362. Delaware³
363. Indiana³
364. Delaware³
365. Delaware³
366. Delaware³
367. United Kingdom³
368. United Kingdom³
369. United Kingdom³
37. United Kingdom³
370. United Kingdom³
371. Delaware³
372. Delaware³
373. Delaware³
374. Delaware³
375. Delaware³
376. Delaware³
377. Delaware³
378. Delaware³
379. Delaware³
38. United Kingdom³
380. Delaware³
381. Delaware³
382. Delaware³
383. Delaware³
384. Delaware³
385. Delaware³
386. Delaware³
387. Delaware³
388. Delaware³
389. Delaware³
39. United Kingdom³
390. Delaware³
391. Delaware³
392. Delaware³
393. Delaware³
394. Delaware³
395. Delaware³
396. Delaware³
397. Delaware³
398. Delaware³
399. Delaware³
40. Delaware³
400. Delaware³
401. Delaware³
402. Delaware³
403. Delaware³
404. Delaware³
405. Delaware³
406. Delaware³
407. Delaware³
408. Delaware³
409. Delaware³
41. Delaware³
410. Florida³
411. Delaware³
412. Delaware³
413. Delaware³
414. Delaware³
415. Delaware³
416. Delaware³
417. Delaware³
418. Delaware³
419. Delaware³
42. Delaware³
420. Delaware³
421. Delaware³
422. Delaware³
423. Delaware³
424. Delaware³
425. Delaware³
426. Delaware³
427. Delaware³
428. Delaware³
429. Delaware³
43. Delaware³
430. Delaware³
431. Delaware³
432. Delaware³
433. Delaware³
434. Delaware³
435. Delaware³
436. Delaware³
437. Delaware³
438. Delaware³
439. Delaware³
44. Delaware³
440. Delaware³
441. Delaware³
442. Delaware³
443. Delaware³
444. Delaware³
445. Delaware³
446. Delaware³
447. Delaware³
448. Delaware³
449. Delaware³
45. Delaware³
450. Delaware³
451. Delaware³
452. Delaware³
453. Delaware³
454. Delaware³
455. Delaware³
456. Delaware³
457. Delaware³
458. Delaware³
459. Delaware³
46. Delaware³
460. Delaware³
461. Delaware³
462. Delaware³
463. Delaware³
464. Delaware³
465. Delaware³
466. Delaware³
467. Delaware³
468. Delaware³
469. Delaware³
47. Ohio³
470. Delaware³
471. Delaware³
472. Delaware³
473. Delaware³
474. Delaware³
475. Delaware³
476. O Delaware³
477. Delaware³
478. Delaware³
479. Delaware³
48. Delaware³
480. Delaware³
481. Delaware³
482. Delaware³
483. Delaware³
484. Delaware³
485. Delaware³
486. Delaware³
487. Delaware³
488. Delaware³
489. Delaware³
49. Delaware³
490. Delaware³
491. Delaware³
492. Delaware³
493. Delaware³
494. Delaware³
495. Delaware³
496. Delaware³
497. Delaware³
498. Delaware³
499. Delaware³
50. United Kingdom³
500. Delaware³
501. Delaware³
502. Delaware³
503. Delaware³
504. Delaware³
505. Delaware³
506. Delaware³
507. Delaware³
508. Delaware³
509. Delaware³
51. Delaware³
510. Delaware³
511. Delaware³
512. Delaware³
513. Delaware³
514. Delaware³
515. Delaware³
516. Delaware³
517. Delaware³
518. Delaware³
519. Delaware³
52. Delaware³
520. Delaware³
521. Delaware³
522. Delaware³
523. Delaware³
524. Delaware³
525. Delaware³
526. Delaware³
527. Delaware³
528. Delaware³
529. Delaware³
53. Delaware³
530. Delaware³
531. Delaware³
532. Delaware³
533. Delaware³
534. Delaware³
535. Delaware³
536. Delaware³
537. Delaware³
538. Delaware³
539. Delaware³
54. United Kingdom³
540. Delaware³
541. Delaware³
542. Delaware³
543. Delaware³
544. Delaware³
545. Delaware³
546. Delaware³
547. Delaware³
548. Delaware³
549. Delaware³
55. Illinois³
550. Delaware³
551. Delaware³
552. Delaware³
553. Delaware³
554. Delaware³
555. Delaware³
556. Delaware³
557. Delaware³
558. Delaware³
559. Delaware³
56. Delaware³
560. Delaware³
561. Delaware³
562. Delaware³
563. Delaware³
564. Delaware³
565. Delaware³
566. Delaware³
567. Delaware³
568. Delaware³
569. Delaware³
57. Delaware³
570. Delaware³
571. Delaware³
572. Maryland³
573. Delaware³
574. Delaware³
575. Delaware³
576. Delaware³
577. Delaware³
578. Delaware³
579. Delaware³
58. Delaware³
580. Delaware³
581. Delaware³
582. Delaware³
583. Delaware³
584. Delaware³
585. Delaware³
586. Delaware³
587. Delaware³
588. Delaware³
589. Delaware³
59. Delaware³
590. Delaware³
591. Delaware³
592. Delaware³
593. Delaware³
594. Delaware³
595. Delaware³
596. Delaware³
597. Delaware³
598. Delaware³
599. Delaware³
60. Delaware³
600. Delaware³
601. Delaware³
602. Delaware³
603. Delaware³
604. Delaware³
605. Delaware³
606. Delaware³
607. Delaware³
608. Delaware³
609. Delaware³
61. Delaware³
610. Delaware³
611. Delaware³
612. Delaware³
613. Delaware³
614. Delaware³
615. Delaware³
616. Delaware³
617. Delaware³
618. Delaware³
619. Delaware³
62. Delaware³
620. Delaware³
621. Delaware³
622. Delaware³
623. Delaware³
624. Delaware³
625. Delaware³
626. Delaware³
627. Delaware³
628. Delaware³
629. Delaware³
63. Delaware³
630. Delaware³
631. Delaware³
632. Delaware³
633. Delaware³
634. Delaware³
635. Delaware³
636. Delaware³
637. Delaware³
638. Delaware³
639. Delaware³
64. Delaware³
640. Delaware³
641. Delaware³
642. Delaware³
643. Delaware³
644. Delaware³

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

Oct 5, 20268-K Regulation FD disclosure³⁸
Oct 1, 20268-K Executive or director change³⁹
Jul 29, 20268-K Results of operations⁴⁰
Jun 5, 20268-K Shareholder vote; Other events⁴¹
May 21, 20268-K Executive or director change; Regulation FD disclosure⁴²
Apr 28, 20268-K Results of operations⁴³
Feb 4, 20268-K Results of operations⁴⁴
Jan 7, 20268-K Executive or director change⁴⁵
Nov 3, 20258-K Other events⁴⁶
Oct 30, 20258-K Results of operations⁴⁷
Oct 15, 20258-K Ended a material agreement⁴⁸
Oct 1, 20258-K Entered a material agreement; Ended a material agreement; New debt or obligation⁴⁹
Jan 4, 2006New chief executive C. Taylor Pickett becomes CEO¹⁴

Calendar

Coming up

Nov 3, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.79 a share, on Oct 30, 2025.⁵⁰

When it reported results

Jul 29, 2026Reported quarterly or annual results⁴⁰
Apr 28, 2026Reported quarterly or annual results⁴³
Feb 4, 2026Reported quarterly or annual results⁴⁴
Oct 30, 2025Reported quarterly or annual results⁴⁷
Jul 31, 2025Reported quarterly or annual results⁵¹
May 1, 2025Reported quarterly or annual results⁵²
Feb 5, 2025Reported quarterly or annual results⁵³
Oct 30, 2024Reported quarterly or annual results⁵⁴

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

339 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 54 major events, 204 insider forms, 26 large holders, 35 other. The latest 20:

Oct 5, 20268-K EDGAR
Oct 1, 20264 EDGAR
Oct 1, 20268-K EDGAR
Sep 30, 20264 EDGAR
Sep 30, 20264 EDGAR
Sep 30, 20264 EDGAR
Sep 30, 20264 EDGAR
Sep 30, 20264 EDGAR
Aug 14, 2026SCHEDULE 13G EDGAR
Aug 11, 20264 EDGAR
Aug 7, 20263 EDGAR
Jul 30, 202610-Q EDGAR
Jul 29, 20268-K EDGAR
Jul 1, 20264 EDGAR
Jul 1, 20264 EDGAR
Jul 1, 20264 EDGAR
Jul 1, 20264 EDGAR
Jul 1, 20264 EDGAR
Jul 1, 20264 EDGAR
Jun 9, 20264 EDGAR

The 339 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

12 open-market trades by officers, directors and large owners since October 2021: 5 buys and 7 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Nov 6, 2025	Gupta VikasChief Investment Officer	Buy	11,500	$42.97	$494.2K	Form 4
Nov 5, 2025	PICKETT C TAYLORCHIEF EXECUTIVE OFFICER	Buy	20,000	$43.14	$862.8K	Form 4
Aug 8, 2025	Egbuonu-Davis LisaDirector	Sale	2,500	$40.16	$100.4K	Form 4
Sep 27, 2024	BOOTH DANIEL JCHIEF OPERATING OFFICER	Sale	56,725	$40.25	$2.3M	Form 4
Sep 27, 2024	STEPHENSON ROBERT OCHIEF FINANCIAL OFFICER	Sale	22,542	$40.19	$906.0K	Form 4
Sep 5, 2024	BOOTH DANIEL JCHIEF OPERATING OFFICER	Sale	25,000	$40.06	$1.0M	Form 4
Aug 26, 2024	STEPHENSON ROBERT OCHIEF FINANCIAL OFFICER	Sale	30,000	$38.78	$1.2M	Form 4
Aug 23, 2024	BOOTH DANIEL JCHIEF OPERATING OFFICER	Sale	25,000	$38.71	$967.8K	Form 4
Aug 13, 2024	Egbuonu-Davis LisaDirector	Sale	1,352	$38.00	$51.4K	Form 4
Nov 16, 2021	Makode Gail DCHIEF LEGAL OFFICER	Buy	1,000	$28.73	$28.7K	Form 4
Nov 15, 2021	Anand Kapila KDirector	Buy	1,000	$28.32	$28.3K	Form 4
Oct 1, 2021	Ballew NealCHIEF FINANCIAL OFFICER	Buy	309	$29.96	$9.3K	Form 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Cohen & SteersSCHEDULE 13G, 8 filings Nov 14, 2024 to Aug 14, 2026⁵⁵
VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 2026⁵⁶
VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 2026⁵⁷
VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 10, 2022 to Mar 27, 2026⁵⁸
State Street CorporationSCHEDULE 13G, 6 filings Feb 10, 2022 to Nov 10, 2025⁵⁹
BlackRockSCHEDULE 13G/A, 6 filings Jan 25, 2022 to Apr 30, 2025⁶⁰

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

Year	Executive	Salary	Total pay
2025	C. Taylor Pickett	$967.0K	$14.0M⁶¹
2025	Robert O. Stephenson	$595.0K	$5.8M⁶¹
2025	Matthew P. Gourmand	$550.0K	$5.1M⁶¹
2025	Vikas Gupta	$525.0K	$4.3M⁶¹
2025	Gail D. Makode	$513.0K	$3.6M⁶¹
2025	Daniel J. Booth		$1.0M⁶¹
2024	Chief Executive Officer	$930.0K	$13.6M⁶¹
2024	Chief Financial Officer	$577.0K	$5.6M⁶¹
2024	Former Chief Operating Officer	$602.0K	$5.3M⁶¹
2024	Chief Legal Officer	$493.0K	$3.5M⁶¹
2023	Chief Executive Officer	$895.0K	$12.1M⁶¹
2023	Former Chief Operating Officer	$579.0K	$5.6M⁶¹
2023	Chief Financial Officer	$555.0K	$5.2M⁶¹
2023	Chief Legal Officer	$474.0K	$3.1M⁶¹

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
BlackRock, Inc.	38,551,916	$1.8B	0.0%	+1,350,553
Vanguard Portfolio Management LLC	27,229,625	$1.3B	0.1%	+106,508
State Street Corp	14,527,955	$692.7M	0.0%	−45,358
Vanguard Capital Management LLC	13,436,631	$640.7M	0.0%	+202,510
Geode Capital Management, LLC	9,141,024	$435.9M	0.0%	+212,917
Invesco Ltd.	5,889,795	$280.8M	0.0%	−33,242
Bank of New York Mellon Corp	5,772,439	$275.2M	0.0%	+1,478,627
Charles Schwab Investment Management Inc	4,818,440	$229.7M	0.0%	+201,768
Dimensional Fund Advisors LP	4,418,159	$210.7M	0.0%	−4,961
Norges Bank	3,989,606	$190.2M	0.0%	New
Daiwa Securities Group Inc.	3,303,471	$157.5M	0.4%	+754,487
Northern Trust Corp	3,296,085	$157.2M	0.0%	+174,079
Morgan Stanley	2,892,204	$137.9M	0.0%	−435,407
Bank Of America Corp /de/	2,891,700	$137.9M	0.0%	−903,030
Quantinno Capital Management LP	2,582,733	$123.1M	0.1%	+456,802
Aqr Capital Management LLC	2,290,479	$109.2M	0.0%	−67,949
UBS Group AG	2,253,738	$107.5M	0.0%	+783,102
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	2,114,655	$100.8M	0.0%	−10,743
Goldman Sachs Group Inc	1,904,560	$90.8M	0.0%	+244,004
Jpmorgan Chase & Co	1,851,042	$89.7M	0.0%	−1,961,920
Vanguard Fiduciary Trust Co	1,881,339	$89.7M	0.0%	+45,743
Legal & General Group Plc	1,853,243	$88.4M	0.0%	+2,677
Allspring Global Investments Holdings, LLC	1,494,297	$72.0M	0.1%	+477,105
Russell Investments Group, Ltd.	1,505,476	$71.8M	0.1%	+496,300
Two Sigma Investments, LP	1,440,518	$68.7M	0.1%	−747,011

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

3 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

Date	Member	Trade	Amount	Vs S&P since	Filing
Mar 7, 2023	Daniel S. GoldmanDemocratic, House	Sale	$1,001 - $15,000	+28.9%	Report
Nov 20, 2020	Thomas R Carper, Senate	Sale	$1,001 - $15,000	+84.9%	Report
Jul 9, 2020	Thomas R Carper, Senate	Sale	$1,001 - $15,000	+95.2%	Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How OMEGA HEALTHCARE INVESTORS INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGAROMEGA HEALTHCARE INVESTORS INC¹
CIK0000888491
Employer ID (EIN)38-3041398⁴
Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company⁴
Incorporated inMaryland⁴
Fiscal year endsDecember 31¹
Industry code (SIC)6798 Real Estate Investment Trusts¹
SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance¹
Business address303 International Circle,, Suite 200, Hunt Valley, MD 21030¹
Phone410-427-1700¹
Shares outstanding303,013,000 as of Jul 27, 2026¹²
Public float$10.7B as of Jun 30, 2025⁴
AuditorErnst & Young LLP, Baltimore, Maryland PCAOB ID 42; it also attests to the company’s internal control over financial reporting⁴
On EDGAR sinceFeb 11, 1994¹
Filings2,367 in all: 4 (1,311), 8-K (314), 10-Q (92), SC 13G/A (73), 5 (49), 424B5 (39), SC 13G (33), DEF 14A (32)¹
All 64 form types
424B3 (31), CORRESP (31), 4/A (29), 10-K (28), UPLOAD (27), 3 (26), 425 (21), S-3ASR (17), DEFA14A (16), 424B2 (15), S-4 (15), EFFECT (12), S-4/A (11), SC 13D/A (10), 10-Q/A (9), FWP (9), PRE 14A (8), S-8 (8), SCHEDULE 13G/A (8), 144 (7), POS AM (7), SCHEDULE 13G (6), 5/A (5), ARS (5), S-3 (5), 8-A12B (4), 8-K/A (4), S-11/A (4), S-3/A (4), 10-K/A (3), AW (3), NT 10-Q (3), 10-K405 (2), 25 (2), 25-NSE (2), 424B7 (2), POSASR (2), S-11 (2), S-3D (2), S-8 POS (2), SC 13D (2), 3/A (1), 424A (1), 424B4 (1), 8-A12B/A (1), 8-A12G (1), CERTNYS (1), CT ORDER (1), DEFR14A (1), DEFS14A (1), POS EX (1), PRER14A (1), PRES14A (1), S-1 (1), S-3DPOS (1), S-3MEF (1)
Latest filingsAnnual report (10-K) Feb 9, 2026
Quarterly report (10-Q) Jul 30, 2026
Proxy statement (DEF 14A) Apr 21, 2026
Latest 8-K (8-K) Oct 5, 2026

Securities registered for trading

Class	Symbol	Exchange
Common Stock	OHI	New York Stock Exchange

From the cover page of the 10-K filed Feb 9, 2026 (Section 12(b) of the Exchange Act).⁴

Risk factors and legal proceedings

The risks OMEGA HEALTHCARE INVESTORS INC names in Item 1A of its 10-K filed Feb 9, 2026: 38 risks under these headings, as written.⁴

Risks Related to the Operators of Our Facilities
The bankruptcy or insolvency of our operators could limit or delay our ability to recover on our investments.
Personal Guarantees and Loans.
Failure by operators to comply with government regulations may adversely impact their ability to make debt or lease payments or meet their obligations to us.
Our operators depend on reimbursement from governmental and other third-party payors, and reimbursement rates from such payors may be reduced, modified or delayed, including through reductions to the Medicare and Medicaid programs for U.S. operators.
We may be unable to find a replacement operator for one or more of our leased properties.
Our operators may be subject to significant legal actions that could result in their increased operating costs and substantial uninsured liabilities, which may affect their ability to meet their obligations to us; and we may become party to such legal actions.
Increased competition as well as increased operating costs, including due to macroeconomic trends, result in lower revenues for some of our operators and may affect the ability of our operators to meet their obligations to us.
We may be unable to successfully foreclose on the collateral securing our loans, and even if we are successful in our foreclosure efforts, we may be unable to successfully find a replacement operator, or operate or occupy the underlying real estate, which may adversely affect our ability to recover our investments.
Uninsured losses or losses in excess of our operators’ insurance coverage could adversely affect our financial position and our cash flow.
Our development and redevelopment projects may not yield anticipated returns.
We are exposed to operational risks with respect to our properties managed in RIDEA structures that could have a material adverse effect on our business, results of operations and financial condition.

The other 27 risks

Risks Related to Us and Our Operations
Severe respiratory disease seasons, epidemics, pandemics or other widespread illnesses could adversely affect our properties and could have a material adverse effect on our business, results of operations, cash flows and financial condition.
There are no assurances of our ability to pay dividends in the future.
We rely on external sources of capital to fund future capital needs, and if we encounter difficulty in obtaining such capital, we may not be able to make future investments necessary to grow our business or meet maturing commitments.
Our ability to raise capital through equity sales is dependent, in part, on the market price of our common stock, and our failure to meet market expectations with respect to our business, or other factors we do not control, could negatively impact such market price and availability of equity capital.
We are subject to risks associated with debt financing, including changes in our credit ratings, which could negatively impact our business and limit our ability to make distributions to our stockholders and to repay maturing debt.
We may be subject to additional risks in connection with our acquisitions of long-term care facilities.
Our assets, including our real estate and loans, are subject to impairment charges, and our valuation and reserve estimates are based on assumptions and may be subject to adjustment.
Our indebtedness could adversely affect our financial condition.
Covenants in our debt documents limit our operational flexibility, and a covenant breach could materially adversely affect our operations.
We are subject to particular risks associated with real estate ownership, which could result in unanticipated losses or expenses.
Our real estate investments are relatively illiquid, and we may not be able to acquire or dispose of properties or otherwise redeploy capital when desired or on favorable terms.
We face possible risks and costs associated with severe weather conditions, natural disasters or the physical effects of climate change.
As an owner or lender with respect to real property, we may be exposed to possible environmental liabilities.
The industry in which we operate is highly competitive. Increasing investor interest in our sector and consolidation at the operator or REIT level could increase competition and reduce our profitability.
Our charter and bylaws contain significant anti-takeover provisions which could delay, defer or prevent a change in control or other transactions that could provide our stockholders with the opportunity to realize a premium over the then-prevailing market price of our common stock.
Ownership of property outside the U.S. may subject us to different or greater risks than those associated with our U.S. investments, including currency fluctuations.
Our assets are concentrated in the long-term care industry and face geographic and operator concentration risk.
Our primary assets are the units of partnership interest in Omega OP and, as a result, we will depend on distributions from Omega OP to pay dividends and expenses.
Members of our management and Board hold partnership interests in Omega OP, and their interests may differ from those of our public stockholders.
Our investments in joint ventures or other equity investments could be adversely affected by shared decision-making authority, our counterparty’s financial condition, and our exposure to potential losses from the actions of our counterparties.
The use of, or inability to use, artificial intelligence by us, our operators, managers, vendors and our investors presents risks and challenges that may adversely impact our business and operating results or the business and operating results of our operators, managers and vendors or may adversely impact the requirements and demand for properties.
Risks Related to Taxation
Qualifying as a REIT involves highly technical and complex provisions of the Code; failure to qualify as a REIT would subject us to increased taxes and impair our ability to expand our business and make distributions; and complying with REIT requirements may affect our profitability. Certain subsidiaries might fail to qualify or remain qualified as a REIT.
There is a risk of changes in the tax law applicable to REITs.
Risks Related to Our Stock and Capital Structure
Our issuance of additional capital stock, warrants, OP units or debt securities, whether or not convertible, may reduce the market price for our outstanding securities, including our common stock, and dilute the ownership interests of existing stockholders, and we may issue securities with greater dividend, liquidation and other rights than our common stock.
General Risk Factors
Our success depends in part on our ability to retain key personnel and our ability to attract or retain other qualified personnel.
We rely on information technology in our operations, and any material failure, inadequacy, interruption or security failure of that technology could harm our business. Privacy and security laws and regulations may also increase costs for our business.
Failure to maintain effective internal control over financial reporting could have a material adverse effect on our business, results of operations, financial condition and stock price.

Legal proceedings

See Note 20 – Commitments and Contingencies – Litigation to the Consolidated Financial Statements, which is hereby incorporated by reference in response to this item.

The opening of Item 3, Legal Proceedings.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROMEGA HEALTHCARE INVESTORS INC filings on SEC EDGAR
2
SEC EDGAROMEGA HEALTHCARE INVESTORS INC filings on SEC EDGAR
3
SEC EDGAROMEGA HEALTHCARE INVESTORS INC annual report, Exhibit 21 (subsidiaries)
4
SEC EDGAROMEGA HEALTHCARE INVESTORS INC annual report, Item 1 (Business)
5
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-K for fiscal 2025
6
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-K for fiscal 2019
7
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-K for fiscal 2020
8
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-K for fiscal 2021
9
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-K for fiscal 2022
10
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-K for fiscal 2019
11
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-Q for fiscal 2026
12
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-Q for fiscal 2026
13
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 10-K for fiscal 2019
14
SEC EDGARC. Taylor Pickett, Chief executive officer
15
SEC EDGARMatthew Paul Gourmand, President
16
SEC EDGARNeal Ballew, Chief financial officer
17
SEC EDGARDaniel J. Booth, Chief operating officer
18
SEC EDGARLucas M. Golem, CHIEF ACCOUNTING OFFICER
19
SEC EDGARNeal Ballew, Chief Accounting Officer
20
SEC EDGARSteven J. Insoft, Chief Corp Development Officer
21
SEC EDGARR. Lee Crabill, Senior Vice President
22
SEC EDGARMichael Ritz, Chief Accounting Officer
23
SEC EDGARLisa Egbuonu-Davis, Board member
24
SEC EDGARKevin J. Jacobs, Board member
25
SEC EDGARKapila K. Anand, Board member
26
SEC EDGARBurke W. Whitman, Board member
27
SEC EDGARBen W. Perks, Board member
28
SEC EDGARCraig M. Bernfield, Board member
29
SEC EDGARNorman Bobins, Board member
30
SEC EDGARBarbara B. Hill, Board member
31
SEC EDGARCraig R. Callen, Board member
32
SEC EDGARBernard J. Korman, Board member
33
SEC EDGAREdward Lowenthal, Board member
34
SEC EDGARHarold J. Kloosterman, Board member
35
SEC EDGARStephen D. Plavin, Board member
36
SEC EDGARThomas F. Franke, Board member
37
SEC EDGARGail D. Makode, General counsel
38
SEC EDGARRegulation FD disclosure
39
SEC EDGARExecutive or director change
40
SEC EDGARResults of operations
41
SEC EDGARShareholder vote; Other events
42
SEC EDGARExecutive or director change; Regulation FD disclosure
43
SEC EDGARResults of operations
44
SEC EDGARResults of operations
45
SEC EDGARExecutive or director change
46
SEC EDGAROther events
47
SEC EDGARResults of operations
48
SEC EDGAREnded a material agreement
49
SEC EDGAREntered a material agreement; Ended a material agreement; New debt or obligation
50
NasdaqNasdaq calendar
51
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 8-K, Item 2.02 (results of operations)
52
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 8-K, Item 2.02 (results of operations)
53
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 8-K, Item 2.02 (results of operations)
54
SEC EDGAROMEGA HEALTHCARE INVESTORS INC 8-K, Item 2.02 (results of operations)
55
SEC EDGARCohen & Steers SCHEDULE 13G on OMEGA HEALTHCARE INVESTORS INC
56
SEC EDGARVANGUARD CAPITAL MANAGEMENT LLC SCHEDULE 13G on OMEGA HEALTHCARE INVESTORS INC
57
SEC EDGARVANGUARD PORTFOLIO MANAGEMENT LLC SCHEDULE 13G on OMEGA HEALTHCARE INVESTORS INC
58
SEC EDGARVANGUARD GROUP INC SCHEDULE 13G/A on OMEGA HEALTHCARE INVESTORS INC
59
SEC EDGARState Street Corporation SCHEDULE 13G on OMEGA HEALTHCARE INVESTORS INC
60
SEC EDGARBlackRock SCHEDULE 13G/A on OMEGA HEALTHCARE INVESTORS INC
61
SEC EDGAROMEGA HEALTHCARE INVESTORS INC proxy statement (DEF 14A), 2025 pay